How Do Telomere Abnormalities Regulate the Biology of Neuroblastoma?

por Akter, Jesmin, Kamijo, Takehiko
Publicado 2021

DNA Ligase 4 Contributes to Cell Proliferation against DNA-PK Inhibition in MYCN-Amplified Neuroblastoma IMR32 Cells

por Ando, Kiyohiro, Suenaga, Yusuke, Kamijo, Takehiko
Publicado 2023

Development of RNA/DNA automated extraction and purification device for infectious disease diagnosis

por Mukae, Kyosuke, Takei, Osamu, Imai, Fumi, Kamijo, Takehiko
Publicado 2023

Comparative epigenomics by machine learning approach for neuroblastoma

por Sugino, Ryuichi P., Ohira, Miki, Mansai, Sayaka P., Kamijo, Takehiko
Publicado 2022

Correlation between the International Neuroblastoma Pathology Classification and genomic signature in neuroblastoma

por Nakazawa, Atsuko, Haga, Chizuko, Ohira, Miki, Okita, Hajime, Kamijo, Takehiko, Nakagawara, Akira
Publicado 2015

Differential impact of Ink4a and Arf on hematopoietic stem cells and their bone marrow microenvironment in Bmi1-deficient mice

por Oguro, Hideyuki, Iwama, Atsushi, Morita, Yohei, Kamijo, Takehiko, van Lohuizen, Maarten, Nakauchi, Hiromitsu
Publicado 2006

Combination of carbon ion beam and gemcitabine causes irreparable DNA damage and death of radioresistant pancreatic cancer stem-like cells in vitro and in vivo

por Sai, Sei, Wakai, Toshifumi, Vares, Guillaume, Yamada, Shigeru, Kamijo, Takehiko, Kamada, Tadashi, Shirai, Toshiyuki
Publicado 2015

CEP131 Abrogates CHK1 Inhibitor-Induced Replication Defects and Is Associated with Unfavorable Outcome in Neuroblastoma

por Ando, Kiyohiro, Cázares-Ordoñez, Verna, Makishima, Makoto, Yokoyama, Atsushi, Suenaga, Yusuke, Nagase, Hiroki, Kobayashi, Shinichi, Kamijo, Takehiko, Koshinaga, Tsugumichi, Wada, Satoshi
Publicado 2020

Minimal Residual Disease Detected by the 7NB-mRNAs ddPCR Assay Is Associated with Disease Progression in High-Risk Neuroblastoma Patients: A Prospective Multicenter Observational S...

por Nishimura, Noriyuki, Ishida, Toshiaki, Yokota, Isao, Matsumoto, Kimikazu, Shichino, Hiroyuki, Fujisaki, Hiroyuki, Sarashina, Takeo, Kamijo, Takehiko, Takimoto, Tetsuya, Iehara, Tomoko, Tajiri, Tatsuro
Publicado 2023

FGFR2 loss sensitizes MYCN‐amplified neuroblastoma CHP134 cells to CHK1 inhibitor–induced apoptosis

por Ando, Kiyohiro, Ohira, Miki, Takada, Ichiro, Cázares‐Ordoñez, Verna, Suenaga, Yusuke, Nagase, Hiroki, Kobayashi, Shinichi, Koshinaga, Tsugumichi, Kamijo, Takehiko, Makishima, Makoto, Wada, Satoshi
Publicado 2021

ATM depletion induces proteasomal degradation of FANCD2 and sensitizes neuroblastoma cells to PARP inhibitors

por Parvin, Sultana, Akter, Jesmin, Takenobu, Hisanori, Katai, Yutaka, Satoh, Shunpei, Okada, Ryu, Haruta, Masayuki, Mukae, Kyosuke, Wada, Tomoko, Ohira, Miki, Ando, Kiyohiro, Kamijo, Takehiko
Publicado 2023

Unique expression features of cancer-type organic anion transporting polypeptide 1B3 mRNA expression in human colon and lung cancers

por Sun, Yuchen, Furihata, Tomomi, Ishii, Seiya, Nagai, Miki, Harada, Manami, Shimozato, Osamu, Kamijo, Takehiko, Motohashi, Shinichiro, Yoshino, Ichiro, Kamiichi, Atsuko, Kobayashi, Kaoru, Chiba, Kan
Publicado 2014

Neurocan, an extracellular chondroitin sulfate proteoglycan, stimulates neuroblastoma cells to promote malignant phenotypes

por Su, Zhendong, Kishida, Satoshi, Tsubota, Shoma, Sakamoto, Kazuma, Cao, Dongliang, Kiyonari, Shinichi, Ohira, Miki, Kamijo, Takehiko, Narita, Atsushi, Xu, Yinyan, Takahashi, Yoshiyuki, Kadomatsu, Kenji
Publicado 2017

Recycling endosomal CD133 functions as an inhibitor of autophagy at the pericentrosomal region

por Izumi, Hideki, Li, Yuanyuan, Shibaki, Masami, Mori, Daisuke, Yasunami, Michio, Sato, Seiji, Matsunaga, Hisashi, Mae, Takao, Kodama, Kenji, Kamijo, Takehiko, Kaneko, Yasuhiko, Nakagawara, Akira
Publicado 2019

Clinical prognostic value of DNA methylation in hepatoblastoma: Four novel tumor suppressor candidates

por Honda, Shohei, Minato, Masashi, Suzuki, Hiromu, Fujiyoshi, Masato, Miyagi, Hisayuki, Haruta, Masayuki, Kaneko, Yasuhiko, Hatanaka, Kanako C., Hiyama, Eiso, Kamijo, Takehiko, Okada, Tadao, Taketomi, Akinobu
Publicado 2016

Combined Genetic and Chromosomal Characterization of Wilms Tumors Identifies Chromosome 12 Gain as a Potential New Marker Predicting a Favorable Outcome()()

por Haruta, Masayuki, Arai, Yasuhito, Okita, Hajime, Tanaka, Yukichi, Takimoto, Tetsuya, Sugino, Ryuichi P., Yamada, Yasuhiro, Kamijo, Takehiko, Oue, Takaharu, Fukuzawa, Masahiro, Koshinaga, Tsugumichi, Kaneko, Yasuhiko
Publicado 2018

Loss of p53 suppresses replication stress-induced DNA damage in ATRX-deficient neuroblastoma

por Akter, Jesmin, Katai, Yutaka, Sultana, Parvin, Takenobu, Hisanori, Haruta, Masayuki, Sugino, Ryuichi P., Mukae, Kyosuke, Satoh, Shunpei, Wada, Tomoko, Ohira, Miki, Ando, Kiyohiro, Kamijo, Takehiko
Publicado 2021

Development of an osteosarcoma model with MYCN amplification and TP53 mutation in hiPS cell‐derived neural crest cells

por Mukae, Kyosuke, Takenobu, Hisanori, Endo, Yuki, Haruta, Masayuki, Shi, Tianyuan, Satoh, Shunpei, Ohira, Miki, Funato, Michinori, Toguchida, Junya, Osafune, Kenji, Nakahata, Tatsutoshi, Kanda, Hiroaki, Kamijo, Takehiko
Publicado 2023

CFC1 is a cancer stemness-regulating factor in neuroblastoma

por Chikaraishi, Koji, Takenobu, Hisanori, Sugino, Ryuichi P., Mukae, Kyosuke, Akter, Jesmin, Haruta, Masayuki, Kurosumi, Masafumi, Endo, Takaho A., Koseki, Haruhiko, Shimojo, Naoki, Ohira, Miki, Kamijo, Takehiko
Publicado 2017

Retrospective Analysis of INRG Clinical and Genomic Factors for 605 Neuroblastomas in Japan: A Report from the Japan Children’s Cancer Group Neuroblastoma Committee (JCCG-JNBSG) †...

por Ohira, Miki, Nakamura, Yohko, Takimoto, Tetsuya, Nakazawa, Atsuko, Hishiki, Tomoro, Matsumoto, Kimikazu, Shichino, Hiroyuki, Iehara, Tomoko, Nagase, Hiroki, Fukushima, Takashi, Yoneda, Akihiro, Tajiri, Tatsuro, Nakagawara, Akira, Kamijo, Takehiko
Publicado 2021